Translational Development Acquisition TDACU
NASDAQ TDACU
$12.57 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Translational Development Acquisition Corp. (TDACU) Return on Capital Employed (2025 - 2026)

Translational Development Acquisition's (TDACU) quarterly Return on Capital Employed came in at 0.48% in Q1 2026, up 7.71% on a QoQ basis from 0.52% in Q4 2025.

Translational Development Acquisition Corp. (TDACU) Return on Capital Employed (2025 - 2026) Analysis & Trends

Translational Development Acquisition (TDACU) has 2 years of Return on Capital Employed data on file, last reported at 0.48% in Q1 2026.

  • Quarterly Return on Capital Employed changed N/A year-over-year to 0.48% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.48% (changed N/A YoY) and the FY2025 annual result came in at 0.53%, down 31.0% from the prior year.
  • Return on Capital Employed climbed to 0.48% in Q1 2026, from 0.52% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.43% in Q2 2025 to a low of 0.52% in Q4 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.48%
Dec 31, 2025 -0.52%
Sep 30, 2025 -0.51%
Jun 30, 2025 -0.43%